Bombay High Court Permits Foeticide for 34-Week Pregnancy with Genetic Disorder
Bombay HC Allows Foeticide for Late-Term Pregnancy with Bone Disorder

Bombay High Court Grants Permission for Foeticide in Late-Term Pregnancy Case

The Bombay High Court has made a significant ruling, permitting foeticide in the uterus prior to the medical termination of a pregnancy that has reached nearly 34 weeks. This decision comes in a case where the fetus has been diagnosed with a genetic bone growth disorder characterized by shortened arms and legs and an enlarged head.

Court's Decision Based on Medical Board Recommendations

Justices Bharati Dangre and Manjusha Deshpande issued the order on Friday, considering the "advanced gestational age" and the detailed report from the medical board of J J Hospital. The court explicitly allowed "petitioner no.1 to terminate the pregnancy by performing feticide in utero prior to delivery." This ruling underscores the judiciary's careful balancing of medical ethics, legal frameworks, and patient rights.

Background of the Case and Initial Medical Opinions

The case was brought forward by a 37-year-old woman and her husband after the medical board of the District Civil Hospital in Thane advised against Medical Termination of Pregnancy (MTP) on March 20. The board opined that the fetus was detected with non-lethal short limb skeletal dysplasia, a condition where no life-threatening anomaly was identified and postnatal survival was deemed possible.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

However, the couple's advocate, Meenaz Kakalia, relied on a previous High Court decision from February 2025, where the J J Hospital board had recommended MTP for a fetus with skeletal dysplasia. Consequently, the High Court directed the J J board to re-examine the petitioner and provide its expert opinion.

Medical Board's Unanimous Recommendation for Termination

The J J Hospital medical board, after thorough examination, unanimously recommended MTP. They concluded that the "foetus is affected by serious congenital abnormality and/or mental abnormalities, and continuation of pregnancy is likely to result in the birth of a child with significant morbidity." Given that the fetus, at approximately 33-34 weeks, might be born alive, and considering the couple's request for foeticide in utero before termination, the board approved the procedure, subject to the High Court's final approval.

Legal Arguments and State's Concerns

During the proceedings, the state's advocate, Molina Thakur, questioned the petitioners' insistence on foeticide, noting that J J Hospital has conducted many MTPs previously and that "termination can be done by following the due process." In response, advocate Kakalia cited the Ministry of Health and Family Welfare's guidance note, which necessitates the foeticide procedure for pregnancies beyond 24 weeks.

Kakalia explained that "because the foetus is formed substantially, if only termination is done, the foetus may still be born alive," highlighting the practical and ethical complexities involved in late-term abortions.

Judicial Observations on Parental Autonomy and State Burden

Justice Dangre addressed the state's concerns by emphasizing the severe implications of the child's condition. She stated, "Now the opinion is the child is going to be born with so many malformations. Who is going to cater to this child? The State? You expect the State to do it? That's why the parents don't want to give birth to this child because that will be a burden."

She further clarified that the procedure likely involves eliminating the fetus before termination to prevent live birth, aligning with the parents' wishes and reducing potential suffering.

Adherence to Central Guidelines and Final Ruling

The judges took note of the Central government's guidelines, formulated at the request of the Supreme Court and High Courts, which outline procedures for MTP, including steps to stop the fetal heartbeat. In allowing the petition, the court concurred with the J J board's opinion, "which has also kept in mind the autonomy and wishes of the patient, who had desired for foeticide in utero prior to delivery."

Since J J Hospital lacks the facility and expertise to perform the foeticide procedure, and the couple preferred a private hospital, the judges permitted it "at their risk and consequences." This decision reflects a nuanced approach to healthcare access and patient choice in complex medical-legal scenarios.

Pickt after-article banner — collaborative shopping lists app with family illustration

Implications of the Ruling

This ruling sets a precedent for handling similar cases involving late-term pregnancies with serious genetic disorders. It highlights the importance of medical board assessments, adherence to governmental guidelines, and respect for parental autonomy in decisions about pregnancy termination. The case also raises broader questions about healthcare infrastructure, ethical considerations in prenatal care, and the role of the judiciary in mediating between medical advice and patient rights.

As medical technology advances and genetic screening becomes more prevalent, such legal decisions will continue to shape the landscape of reproductive rights and healthcare policies in India. The Bombay High Court's careful consideration of all factors—medical, legal, and personal—demonstrates a commitment to justice and compassion in challenging circumstances.